Company / Return on Assets (ROA)
Sunshine Biopharma Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-17.1%
FY2025
5-year range
-126.4% / -14.7%
FY2021-FY2025
Trend
-15.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -2566.5% in FY2016 to -14.7% in FY2024.
Based on SEC 10-K filings.
-17.1% in FY2025 with a 5-year CAGR of +141.7%.
Improved from -97.8% to -17.1% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +25.5pp
- 5-Year Change
- +141.7pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 15.8% year-over-year.
- Peak return on assets (roa) was recorded in FY2024.
- Lowest return on assets (roa) in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -17.1% | -15.8% |
| FY2024 | -14.7% | +84.9% |
| FY2023 | -97.8% | -130.0% |
| FY2022 | -42.5% | +66.3% |
| FY2021 | -126.4% | +20.4% |
| FY2020 | -158.8% | +92.8% |
| FY2019 | -2197.0% | -2321.4% |
| FY2018 | -90.7% | +93.3% |
| FY2017 | -1358.0% | +47.1% |
| FY2016 | -2566.5% | -793.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026